Archive of Postings to PHARM-POLICY
PHARM-POLICY
This is a small "discussion" list which discusses issues relating
to pharmaceutical development. The issues of particular interest
to PHARM-POLICY subscribers are pharmaceutical drug pricing, the
federal government's "reasonable pricing" clause for government
developed drugs, the GATT Intellectual Property provisions as
they relate to compulsory licensing and other similar issues.
Subscription requests to pharm-policy are by electronic mail, sent
to listproc@tap.org, with the message:
subscribe pharm-policy yourfirstname yourlastname
[ Go to the Index of all Archived Lists ]
[ Go to the Index of all Archived Lists ]
[Prev Page][Next Page]
Mail converted by MHonArc 2.3.3